Breaking News
MAHA's "Handpicked" Biosecurity Veteran
Remember back in 2022 when John Bolton "slipped" & admitted that he's helped plan Coup
Starship's Tenth Flight Test
What Are The Real Reasons Behind Washington's Latest Show Of Force Against Venezuela?
Top Tech News
Video Games At 30,000 Feet? Starlink's Airline Rollout Is Making It Reality
Automating Pregnancy through Robot Surrogates
SpaceX launches Space Force's X-37B space plane on 8th mystery mission (video)
This New Bionic Knee Is Changing the Game for Lower Leg Amputees
Grok 4 Vending Machine Win, Stealth Grok 4 coding Leading to Possible AGI with Grok 5
Venus Aerospace Hypersonic Engine Breakthroughs
Chinese Scientists Produce 'Impossible' Steel to Line Nuclear Fusion Reactors in Major Break
1,000 miles: EV range world record demolished ... by a pickup truck
Fermented Stevia Extract Kills Pancreatic Cancer Cells In Lab Tests
3D printing set to slash nuclear plant build times & costs
Tumor-Destroying Sound Waves Treatment Coming to a Hospital Near You For Liver Cancer
Known as "histotripsy," the method and machinery have already been tested successfully in animals and humans, and has just been approved for use by the FDA.
HistoSonics is a company founded in 2009 to create an ultrasound device that both screens for tumors and administers histotripsy. It was born from the efforts of scientists at the University of Michigan who co-founded the firm.
"Histotripsy is an exciting new technology that, although it is in early stages of clinical use, may provide a noninvasive treatment option for patients with liver cancer. Hopefully it can be combined with systemic therapies for a synergistic therapeutic effect," said Mishal Mendiratta-Lala, professor of radiology with Michigan Medicine.
Mendiratta-Lala was the principal investigator of an FDA human trial started in 2021 which confirmed that HistoSonic's device, called Edison, can destroy cancer tumors.